ThinkSabio

$VNDA

$4.40▲ +10.3% YTD

13 SEC 13D/G filings tracked · Last updated Oct 28, 2026

Filing History
News
VNDA ▲ +10.3% - Vanda Pharmaceuticals Inc.
CP $4.40▲ +10.3%Oct 28, 2026 · ThinkSabio Blog

$VNDA Vanda Pharma Q3 EPS $(0.37) Beats $(0.68) Estimate, Sales $69.815M Beat $69.202M Estimate / Vanda Pharmaceuticals FY2026 Revenue expected to be…

News
VNDA ▲ +10.5% - Vanda Pharmaceuticals Inc.
CP $4.41▲ +10.5%Oct 28, 2026 · ThinkSabio Blog

$VNDA VNDA - Vanda Pharmaceuticals Reports Third Quarter 2026 Financial Results…

SEC 13D/G
VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks Simplified
$3.99▼ -51.64%Oct 27, 2026 · ThinkSabio Blog

$VNDA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VNDA Vanda Pharmaceuticals Inc. : $3.99 Sector: Healthcare | YT…

News
VNDA ▼ -0.3% - Vanda Pharmaceuticals Inc.
CP $3.93▲ -0.3%Oct 27, 2026 · ThinkSabio Blog

$VNDA VNDA - Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting…

News
VNDA ▼ -2.4% - Vanda Pharmaceuticals Inc.
CP $4.05▲ -2.4%Oct 21, 2026 · ThinkSabio Blog

$VNDA VNDA - Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026…

News
VNDA ▼ -10.9% - Vanda Pharmaceuticals Inc.
CP $3.83▲ -10.9%Oct 14, 2026 · ThinkSabio Blog

$VNDA trial for VQW-765 does not meet primary endpoint…

News
VNDA ▼ -10.9% - Vanda Pharmaceuticals Inc.
CP $3.83▲ -10.9%Oct 14, 2026 · ThinkSabio Blog

$VNDA VNDA VNDA - Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program…

SEC 13D/G
VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (09-OCT-2026) | ThinkSabio - Stocks Simplified
$4.58▼ -44.48%Oct 9, 2026 · ThinkSabio Blog

$VNDA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VNDA Vanda Pharmaceuticals Inc. : $4.58 Sector: Healthcare | YT…

News
VNDA ▲ +0.4% - Vanda Pharmaceuticals Inc.
CP $4.85▲ +0.4%Oct 2, 2026 · ThinkSabio Blog

$VNDA VNDA - Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual Meeting…

News
VNDA ▲ +10.8% - Vanda Pharmaceuticals Inc.
CP $5.73▲ +10.8%Sep 29, 2026 · ThinkSabio Blog

$VNDA VNDA - Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder…

News
VNDA ▲ +1.8% - Vanda Pharmaceuticals Inc.
CP $5.53▲ +1.8%Sep 2, 2026 · ThinkSabio Blog

$VNDA VNDA - Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences…

SEC 13D/G
VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks Simplified
$5.50▼ -33.33%Aug 19, 2026 · ThinkSabio Blog

$VNDA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VNDA Vanda Pharmaceuticals Inc. : $5.50 Sector: Healthcare | YT…

SEC 13D/G
VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified
$5.17▼ -37.33%Aug 13, 2026 · ThinkSabio Blog

$VNDA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VNDA Vanda Pharmaceuticals Inc. : $5.17 Sector: Healthcare | YT…